Logo

Benitec Licenses ddRNAi Technology to Genoway of France to Create Transgenic Animal Models

Mar 22, 2005

NEW YORK, March 22 (GenomeWeb News) - Benitec has licensed its DNA-directed RNA interference technology to Genoway of France, Benitec said today.

 

Under the non-exclusive license, Genoway, based on Lyon, may develop transgenic animals using Benitec's ddRNAi technology. Benitec will receive an upfront license fee and ongoing royalties.

 

Genoway provides mouse and rat models for basic research and drug discovery and has already been using RNAi technology in vivo.

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.